Reshma Kewalramani Biography
Reshma Kewalramani, is known as the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company located in Boston, Massachusetts, as of April 1, 2020. Likewise, she is the first female CEO of a large US biotech company.
How old is Reshma Kewalramani? – Age
The president and chief executive officer is 50 years old as of 2023. She was born in 1973, in Mumbai, India, where he also grew up.
How tall is Reshma Kewalramani? – Height
Wendell is 5 feet 8 inches (1.73 m) tall.
Reshma Kewalramani Mother, Father – Family
Kewalramani was born and raised in Bombay, India. In addition, she and her family immigrated to the US when she was 11 years old.
Reshma Kewalramani Education
In 1998, she graduated from the seven-year liberal arts/medical education program located at Boston University, Phi Beta Kappa, Summa Cum Laude. Later, she finished her internship and residency at the Massachusetts General Hospital and also her fellowship in nephrology at the Massachusetts General Hospital and Brigham as well as Women’s Hospital combined program. Moreover, after finishing her fellowship in clinical nephrology she did research in transplantation. Besides, she graduated from the General Management Program at Harvard Business School in 2015.
Is Reshma Kewalramani Married? – Husband
Kewalramani resides in Massachusetts, and blessed with twin sons.
Kewalramani started her career as a physician at Massachusetts General Hospital and Brigham and also Women’s Hospital. In addition, she was also a physician at the Massachusetts Eye and Ear Infirmary and the Massachusetts Institute of Technology.
She later entered the biopharma sector, serving for Amgen for over 12 years, where she held leadership positions in research and also development. Later in 2017 she joined Vertex Pharmaceuticals. Besides, she assumed the role of president and CEO on April 1, 2020 and as well is a member of the Vertex Board of Directors.
Since she was CEO, Vertex has developed cystic fibrosis therapy drug Trikafta, APOL1-mediated kidney disease and experimental apolipoprotein L1 inhibitor, VX-147, and also pain programs into the clinic. Likewise, the company has as well partnered with CRISPR Therapeutics to develop gene-editing therapies for the treatment of sickle cell disease and also beta thalassemia.
Boards and awards
Kewalramani is as well a member of the Massachusetts General Hospital Board of Trustees, the Biomedical Science Careers Program Board and also the Boston University School of Medicine Dean’s Advisory Board. Furthermore, she is a member of the board of directors of Ginkgo Bioworks, and became on the inaugural board of directors of the Kidney Health Initiative.
Reshma Kewalramani Net Worth
Citing his career, Kewalramani sits at an estimated net worth of at least $70.8 Million dollars.
Reshma Kewalramani Instagram
You can find and follow Pierce on Instagram using the account @wendellpcg